From: Importance of oxidative stress in the evaluation of acute pulmonary embolism severity
Controls (n:21) | Low-risk (n:14) | Intermediate-risk (n:16) | High-risk (n:17) | p | |
---|---|---|---|---|---|
Gender (M/F) | 11/10 | 7/7 | 4/12 | 11/6 | – |
BMI (mm2/kg) | 25.34 ± 2.51 | 27.83 ± 5.54 | 29.99 ± 4.11 | 27.87 ± 4.95 | > 0.05 |
Hypertension (n) | – | 5 | 8 | 7 | |
Diabetes mellitus (n) | – | 2 | 3 | 1 | |
COPD (n) | – | 3 | 1 | 5 | |
Immobilization (n) | – | 10 | 10 | 12 | |
Trauma (n) | – | 0 | 2 | 0 | |
Malignancy (n) | – | 4 | 5 | 6 | |
Pregnancy (n) | – | 1 | 1 | 1 | |
Major general surgery (n) | – | 3 | 5 | 5 | |
Pulse rate per minute | – | 94.79 ± 10.8 | 87.88 ± 14.19 | 98.71 ± 19.41 | < 0.05 |
Number of breaths per minute | – | 22.21 ± 5.12 | 23.75 ± 4.91 | 25.18 ± 5.26 | < 0.05 |
Systolic blood pressure (mmHg) | 120 ± 8.15 | 119.29 ± 11.91 | 120.31 ± 14.66 | 92.65 ± 13.71 | < 0.05 |
Diastolic blood pressure (mmHg) | 82.34 ± 3.64 | 72.86 ± 8.25 | 75.31 ± 9.57 | 59.71 ± 11.79 | < 0.01 |
C-reactive protein (mg/dL) | 1.87 ± 0.09 | 44.64 ± 39.16 | 54.62 ± 43.93 | 55.04 ± 44.73 | < 0.01 |
Leukocyte counts ( /mm³) | 7896 ± 1498 | 8945 ± 3812 | 9281 ± 3466 | 9730 ± 4815 | < 0.05 |
Hemoglobin (g/dL) | 12.46 ± 1.74 | 12.44 ± 1.5 | 10.89 ± 3.3 | 11.81 ± 2.76 | > 0.05 |
Hematocrit (%) | 41.85 ± 3.76 | 35.73 ± 4.22 | 34.24 ± 5.53 | 35.98 ± 8.27 | > 0.05 |
Platelet counts ( /mm³) | 325.87 ± 48.98 | 273.79 ± 93.67 | 288.5 ± 164.3 | 199.29 ± 91.27 | < 0.01 |
Albumin (g/dL) | 4.12 ± 0.34 | 3.59 ± 0.29 | 3.52 ± 0.45 | 3.01 ± 0.91 | > 0.05 |
Total protein (g/dL) | 7.83 ± 0.2 | 6.76 ± 0.35 | 6.67 ± 0.4 | 6.36 ± 0.33 | > 0.05 |
NT-proBNP (pg/mL) | 35.72 ± 24.65 | 75.21 ± 67.2 | 274.32 ± 490.56 | 809.76 ± 705.12 | < 0.001 |
cTnT (ng/mL) | 0 ± 0.01 | 0 ± 0.01 | 0.03 ± 0.09 | 0.04 ± 0.09 | > 0.05 |